Evaluation of Midkine as a Diagnostic Serum Biomarker in Hepatocellular Carcinoma

Abstract

Serum MDK is significantly elevated in most hepatocellular carcinomas, including those with negative AFP and at an early stage, which may serve as a novel diagnostic marker in early diagnosis and postoperative monitoring of hepatocellular carcinomas.